DexCom (DXCM) Reiterated at Buy by Benchmark as Revenue Forecast Raised

June 23, 2026 6:49 AM

Benchmark analyst Bruce Jackson reiterated a Buy rating and $77.00 price target on DexCom (NASDAQ: DXCM).The analyst commented, "For 2Q ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found